The packaging image may vary depending on the country in which it is marketed.

Logotipo CZ Vaccines
Manufacturer
CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription

DILPHES 4

Inactivated vaccine against pasteurellosis in cattle, sheep andgoats, in an injectable suspension
Target species
Cattle icon
Cattle
Sheep icon
Sheep
Goats icon
Goats
Composition per dose (2 ml)
Active substance:
Inactivated Pasteurella multocidainactivada, serotype A, strain NCTC 12177 and
Inactivated Pasteurella multocida serotype 6B, strain CECT 962 ≥104 DP50 *
Inactivated Mannheimia haemolytica, serotype A1, strain ATCC 33365 and
Inactivated Mannheimia haemolytica serotype A2, strain CECT 924 ≥41,08 UE**

*DP50: Protective dose 50% in mice.

**EU: Antibody titre in vaccinated sheep expressed in ELISA units.


Adjuvant:
Aluminium hydroxide (Al+3) 2,8 mg
Indications
Active immunisation to prevent infections caused by Pasteurella multocida and Mannheimia Poulthaemolytica.
  • Onset of immunity: 21 days.
Route of administration
Subcutaneous.
Dosage
Dose:
  • Cattle over 6 months of age: 5 ml.
  • Cattle under 6 months of age: 2 ml.
  • Sheep and goats from 2 months of age: 2 ml.
Vaccination schedule:
  • Primary vaccination: 2 doses. Separated by a 30-day interval.
    Pregnant females: Second dose 4–6 weeks before parturition.
 
  • Revaccination: 1 dose. Annual.
    Pregnant females: Administer before parturition.
Withdrawal period
Zero days.

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
CZ Vaccines S.A.U.
Medicamento sujeto a prescripción veterinaria

DILPHES 4

Inactivated vaccine against pasteurellosis in cattle, sheep andgoats, in an injectable suspension
Composición por dosis (2 ml)
Active substance:
Inactivated Pasteurella multocidainactivada, serotype A, strain NCTC 12177 and
Inactivated Pasteurella multocida serotype 6B, strain CECT 962 ≥104 DP50 *
Inactivated Mannheimia haemolytica, serotype A1, strain ATCC 33365 and
Inactivated Mannheimia haemolytica serotype A2, strain CECT 924 ≥41,08 UE**

*DP50: Protective dose 50% in mice.

**EU: Antibody titre in vaccinated sheep expressed in ELISA units.


Adjuvant:
Aluminium hydroxide (Al+3) 2,8 mg
Indicaciones
Active immunisation to prevent infections caused by Pasteurella multocida and Mannheimia Poulthaemolytica.
  • Onset of immunity: 21 days.
Vía de administración
Subcutaneous.
Posología
Dose:
  • Cattle over 6 months of age: 5 ml.
  • Cattle under 6 months of age: 2 ml.
  • Sheep and goats from 2 months of age: 2 ml.
Pauta de vacunación
  • Primary vaccination: 2 doses. Separated by a 30-day interval.
    Pregnant females: Second dose 4–6 weeks before parturition.
 
  • Revaccination: 1 dose. Annual.
    Pregnant females: Administer before parturition.
Tiempo de espera
Zero days.
Scroll to Top